Moderna Inc
MRNA
Market Cap$40.65B
Close$
$-69.95
163.4% downside
Current Fair Value
163.4% downsideOvervalued by 163.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $40.65 Billion |
|---|---|
| Enterprise Value | $32.63 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-12.34 |
| Beta | 0.0 |
| Outstanding Shares | 382,879,612 |
| Avg 30 Day Volume | 3,138,320 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.62 |
|---|---|
| PEG | 10.12 |
| Price to Sales | 6.49 |
| Price to Book Ratio | 3.06 |
| Enterprise Value to Revenue | 4.76 |
| Enterprise Value to EBIT | -7.7 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
ESG Score
No data
About Moderna Inc
CEO: Stephane Bancel